|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 31/568 | (2006.01) |
| A61K 31/575 | (2006.01) | ||
| A61K 31/56 | (2006.01) | ||
| A61P 43/00 | (2006.01) | ||
| A61P 1/16 | (2006.01) | ||
| A61K 35/12 | (2015.01) |
| (11) | Number of the document | 3639828 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19214560.5 |
| Date of filing the European patent application | 2014-12-23 | |
| (97) | Date of publication of the European application | 2020-04-22 |
| (45) | Date of publication and mention of the grant of the patent | 2021-12-01 |
| (46) | Date of publication of the claims translation | 2022-03-25 |
| (30) | Number | Date | Country code |
| 201361920617 P | 2013-12-24 | US |
| (72) |
REN, Shunlin , US
THEEUWES, Felix , US
BROWN, James E. , US
LIN, WeiQi , US
|
| (73) |
Virginia Commonwealth University ,
800 East Leigh Street
Suite 3000, Richmond, VA 23298,
US
Durect Corporation , 10240 Bubb Road, Cupertino, CA 95014-4166, US |
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Deguoninių cholesterolio sulfatų (OCS) panaudojimas ūminio kepenų nepakankamumo gydymui |
| USE OF OXYGENATED CHOLESTEROL SULFATES (OCS) FOR TREATING ACUTE LIVER FAILURE |
| Payment date | Validity (years) | Amount | |
| 2023-12-04 | 10 | 231.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2024-12-23 |